"10.1371_journal.pone.0086254","plos one","2014-01-23T00:00:00Z","Viraj Kulkarni; Antonio Valentin; Margherita Rosati; Candido Alicea; Ashish K Singh; Rashmi Jalah; Kate E Broderick; Niranjan Y Sardesai; Sylvie Le Gall; Beatriz Mothe; Christian Brander; Morgane Rolland; James I Mullins; George N Pavlakis; Barbara K Felber","Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America; Inovio Pharmaceuticals, Inc., Blue Bell, Pennsylvania, United States of America; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America; IrsiCaixa AIDS Research Institute-HIVACAT, Autonomous University of Barcelona, Barcelona, Spain; Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain; Department of Microbiology, University of Washington, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America","Conceived and designed the experiments: GNP BKF AV VK M Rolland JIM BM CB SLG. Performed the experiments: VK AV M Rosati CA AKS RJ. Analyzed the data: VK AV GNP BKF. Contributed reagents/materials/analysis tools: KEB NYS. Wrote the paper: BKF GNP AV JIM.","GNP and BKF are inventors on US Government-owned patents and patent applications related to DNA vaccines and gene expression optimization that have been licensed to several companies. GNP, JIM, and BKF are inventors on a US Government and University of Washington co-owned patent application relating to material pertinent to this article. NYS and KEB are full time employees of Inovio Pharmaceuticals and as such receive compensation in the form of salary and stock options. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Viraj Kulkarni","VK",15,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
